BeiGene, Ltd. (NASDAQ:BGNE – Get Rating) major shareholder Advisors Ltd. Hhlr sold 1,163,825 shares of the company’s stock in a transaction that occurred on Thursday, June 8th. The stock was sold at an average price of $218.14, for a total value of $253,876,785.50. Following the completion of the sale, the insider now directly owns 145,879,233 […]
XY Capital Ltd bought a new position in BeiGene, Ltd. (NASDAQ:BGNE – Get Rating) during the fourth quarter, according to its most recent 13F filing with the SEC. The fund bought 5,018 shares of the company’s stock, valued at approximately $1,104,000. BeiGene comprises about 0.7% of XY Capital Ltd’s holdings, making the stock its 23rd […]
BeiGene, Ltd. (NASDAQ:BGNE – Get Rating) has been assigned an average recommendation of “Moderate Buy” from the nine research firms that are presently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12-month price objective among […]
BeiGene (NASDAQ:BGNE – Get Rating) posted its earnings results on Thursday. The company reported ($3.34) earnings per share for the quarter, topping the consensus estimate of ($3.66) by $0.32, Briefing.com reports. The firm had revenue of $447.80 million for the quarter, compared to analyst estimates of $449.44 million. BeiGene had a negative return on equity […]
LexaGene Holdings Inc. (CVE:LXG – Get Rating) shares fell 19.2% during trading on Thursday . The stock traded as low as C$0.10 and last traded at C$0.11. 2,135,377 shares were traded during mid-day trading, an increase of 1,156% from the average session volume of 170,061 shares. The stock had previously closed at C$0.13. LexaGene Stock […]